| Home > Authorities > Periodicals > Molecular pharmacology > print |
| 001 | 29672 | ||
| 005 | 20260201200959.0 | ||
| 022 | _ | _ | |2 (DE-600)124034-1 |a 0026-895X |
| 022 | _ | _ | |a 0026-895X |l 1521-0111 |
| 022 | _ | _ | |a 1521-0111 |
| 024 | 7 | _ | |2 ZDBID |a PERI:(DE-600)1475030-2 |
| 024 | 7 | _ | |2 ZDBPPN |a ZDPPN:019680783 |
| 024 | 7 | _ | |2 EZBID |a PERI:(DE-606)1938 |
| 024 | 7 | _ | |2 EZBID |a PERI:(DE-606)1938 |
| 024 | 7 | _ | |2 OCLC |a OCLC:643959273 |
| 024 | 7 | _ | |2 ISI |a WOS:MOLECULAR PHARMACOLOGY |
| 024 | 7 | _ | |2 SCOPUS |a SCOPUS:19963 |
| 024 | 7 | _ | |2 Medline |a medline:0035623 |
| 024 | 7 | _ | |2 JCR |a JCR:MOL PHARMACOL |
| 030 | _ | _ | |2 DE-600 |a MOPMA |
| 035 | _ | _ | |a PERI:(DE-600)1475030-2 |
| 040 | _ | _ | |a 9001 |b ger |c DE-101 |d JOIN² |e JOIN² journal identification |
| 041 | _ | _ | |a eng |
| 044 | _ | _ | |c XD-US |
| 082 | _ | _ | |2 22sdnb |a 610 |q DE-600 |
| 082 | 7 | 4 | |2 22sdnb |a 610 |q DE-600 |
| 084 | _ | _ | |2 fid |a PHARM |q DE-84 |
| 084 | _ | _ | |2 ssgn |a 15,3 |
| 084 | _ | _ | |2 stub |a MED 900z |
| 210 | 0 | _ | |2 DE-600 |a Mol. Pharmacol. |
| 210 | 0 | _ | |2 DE-600 |a Molec Pharm |
| 210 | 0 | _ | |2 iso |a Mol Pharmacol |
| 210 | 0 | _ | |2 dnlm |a Mol Pharmacol |
| 210 | 0 | _ | |2 iso |a Mol Pharmacol |
| 242 | 2 | 0 | |2 DE-600 |a Molecular pharmacology |c American Society for Pharmacology and Experimental Therapeutics |y en |
| 242 | 2 | 0 | |2 DE-600 |a Molecular pharmacology |c American Society for Pharmacology and Experimental Therapeutics |
| 245 | _ | _ | |2 DE-600 |a Molecular pharmacology |c American Society for Pharmacology and Experimental Therapeutics |h online, print |
| 246 | 3 | _ | |2 DE-600 |a Molecular pharmacology |
| 246 | 3 | _ | |a Molecular pharmacology online |
| 246 | 3 | _ | |a Molecular pharmacology |
| 260 | _ | _ | |a Bethesda, Md. |b ASPET |c 1965- |
| 260 | _ | 1 | |0 Host:(DE-Juel1)3067 |2 DE-Juel1 |a American Society for Pharmacology and Experimental Therapeutics (ASPET) |
| 264 | 3 | 1 | |a Bethesda, Md. |b ASPET |c 1965- |
| 362 | 0 | _ | |2 DE-600 |a 1.1965 - |
| 363 | 0 | 1 | |2 DE-600 |8 1.1\x |a 1 |i 1965 |
| 380 | _ | _ | |2 marcgt |a journal |
| 500 | _ | _ | |a Automatically generated record. (Updated: 2025-11-13) |
| 540 | _ | _ | |5 PubMed Central |a Free access after 12 months. OpenAccess, coverage |d 2025-11-13 |
| 650 | _ | 7 | |0 4170397-2 |2 gnd |9 rswk-swf |a Molekularpharmakologie |
| 650 | _ | 7 | |0 4067488-5 |2 gnd |9 rswk-swf |a Zeitschrift |
| 650 | _ | 7 | |0 4511937-5 |2 gnd |9 rswk-swf |a Online-Ressource |
| 650 | _ | 7 | |0 ASJC:3004 |2 ASJC |a Pharmacology |
| 650 | _ | 7 | |0 ASJC:1313 |2 ASJC |a Molecular Medicine |
| 653 | 1 | 0 | |2 EZB-Subject |a Medicine |
| 653 | 1 | 0 | |2 EZB-Subject |a Chemistry and Pharmacology |
| 653 | 1 | 0 | |2 EZB-Keyword |a Pharmazie |
| 653 | 1 | 0 | |2 EZB-Keyword |a Pharmakologie |
| 710 | 2 | _ | |0 (DE-101)000053147 |2 gnd |4 isb |a American Society for Pharmacology and Experimental Therapeutics |e Herausgebendes Organ |
| 776 | 0 | 8 | |2 DE-600 |d Bethesda, Md. : American Society for Pharmacology and Experimental Therapeutics, 1965-2011 |i Erscheint auch als |n Druck-Ausgabe |t Molecular pharmacology |w (DE-600)124034-1 |x 0026-895X |
| 856 | 4 | _ | |d 0 |u https://ezb.ur.de/?1475030-2 |y EZB |
| 856 | 4 | _ | |d 0 |u https://molpharm.aspetjournals.org |y Verlag |
| 856 | 4 | _ | |d 0 |u https://www.ncbi.nlm.nih.gov/pmc/?term="Mol Pharmacol"[journal] |y PubMed Central |
| 856 | 4 | _ | |d 0 |u https://www.sciencedirect.com/journal/molecular-pharmacology |y Verlag |
| 880 | 1 | _ | |2 DE-600 |a Molecular pharmacology |c American Society for Pharmacology and Experimental Therapeutics |
| 909 | C | O | |o oai:juser.fz-juelich.de:63273 |p authority:PERI |p authority |
| 909 | C | O | |o oai:juser.fz-juelich.de:63273 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b MOL PHARMACOL : 2022 |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0320 |2 StatID |a DBCoverage |b PubMed Central |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Clarivate Analytics Master Journal List |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1190 |2 StatID |a DBCoverage |b Biological Abstracts |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0160 |2 StatID |a DBCoverage |b Essential Science Indicators |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0113 |2 StatID |a WoS |b Science Citation Index Expanded |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |d 2025-11-13 |
| 915 | _ | _ | |0 StatID:(DE-HGF)9900 |2 StatID |a IF < 5 |d 2025-11-13 |
| 936 | _ | _ | |a Fast Forward (publish-ahead-of-print) articles are freely available upon publication. 2025 Verlagswechsel zu Elsevier. |
| 980 | _ | _ | |a PERI |
| 980 | _ | _ | |a AUTHORITY |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|